the role of ezh2 mutations in mds
Published 5 years ago • 567 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
2:08
somatic mutations in mds as targets for therapy
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
2:49
the role of the immune system in the pathophysiology of mds
-
3:10
the role of ngs in mds diagnosis
-
4:37
mds pathology: recent advances and the role of the pathologist
-
1:17
phase ii study of tosedostat in mds
-
4:12
barry's story: what advice do you have for other patients on their journey with mds-related anemia?
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
6:36
mds: low-risk disease treatment options
-
1:41
an overview of the mds diagnosis pathway
-
3:11
clinical characteristics of h-mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
2:43
novel therapies in the future of mds treatment
-
1:47
the role of ngs in improving diagnosis in mpns
-
2:04
state-of-the-art treatment for hr-mds
-
2:17
oncogenic mutational networks in acute myeloid leukemia (aml) and myelodysplastic syndromes (mds)
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
1:17
exciting novel treatments being developed for mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds